20Jul 2022
Investigation of serum and adipose tissue levels of asprosin in patients with severe obesity undergoing sleeve gastrectomy

Investigation of serum and adipose tissue levels of asprosin in patients with severe obesity undergoing sleeve gastrectomy

This study aimed to reveal the relationship between obesity and asprosin (fibrillin‐1) in patients undergoing bariatric surgery and to investigate the role of asprosin in obesity etiopathogenesis. A significant intergroup difference in terms of mean asprosin levels in adipose tissue was noted. Serum asprosin levels decreased significantly six months after bariatric surgery. Adipose tissue of patients with obesity showed high asprosin levels and immunoreactivity. In conclusion, asprosin levels in adipose tissue were considered a potential independent risk factor in obesity etiopathogenesis.

  • #endo-diabetology

Like

Save

Share